Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
494.61 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 9,869.2 | 8,930.7 | 7,574.4 | 6,205.683 | 4,162.821 | 3,047.597 | 2,488.652 | 1,702.177 | 1,032.336 | 580.415 | 1,211.975 | 1,527.042 | 1,410.626 | 143.37 | 102.049 | 175.504 | 199.012 | 216.356 | 160.89 | 102.717 | 69.141 | 161.085 | 167.49 | 78.127 | 61.6 | 44.4 | 43.8 | 13.3 | 22.1 | 19.6 | 27.9 | 3.8 | 3.2 | 2.3 |
Cost of Revenue
| 1,262.2 | 1,080.3 | 904.2 | 736.3 | 547.758 | 409.539 | 275.119 | 210.46 | 125.542 | 60.987 | 130.277 | 279.885 | 80.505 | 12.73 | 14.202 | 15.686 | 13.904 | 12.17 | 10.098 | 5.649 | 3.126 | 28.281 | 39.629 | 4.082 | -3.4 | -4.5 | -3.6 | -3.2 | -3.7 | -3.5 | -3.9 | -2.8 | -1.8 | 0 |
Gross Profit
| 8,607 | 7,850.4 | 6,670.2 | 5,469.383 | 3,615.063 | 2,638.058 | 2,213.533 | 1,491.717 | 906.794 | 519.428 | 1,081.698 | 1,247.157 | 1,330.121 | 130.64 | 87.847 | 159.818 | 185.108 | 204.186 | 150.792 | 97.068 | 66.015 | 132.804 | 127.861 | 74.045 | 65 | 48.9 | 47.4 | 16.5 | 25.8 | 23.1 | 31.8 | 6.6 | 5 | 2.3 |
Gross Profit Ratio
| 0.872 | 0.879 | 0.881 | 0.881 | 0.868 | 0.866 | 0.889 | 0.876 | 0.878 | 0.895 | 0.893 | 0.817 | 0.943 | 0.911 | 0.861 | 0.911 | 0.93 | 0.944 | 0.937 | 0.945 | 0.955 | 0.824 | 0.763 | 0.948 | 1.055 | 1.101 | 1.082 | 1.241 | 1.167 | 1.179 | 1.14 | 1.737 | 1.563 | 1 |
Reseach & Development Expenses
| 3,162.9 | 2,540.3 | 3,051.1 | 1,829.537 | 1,754.54 | 1,416.476 | 1,324.625 | 1,047.69 | 996.17 | 855.506 | 918.783 | 806.185 | 707.706 | 637.416 | 550.685 | 516.292 | 513.054 | 371.713 | 248.54 | 192.162 | 199.636 | 203.018 | 148.673 | 84.921 | 72.2 | 58.7 | 51.6 | 35.2 | 41.5 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 401.429 | 352.58 | 289.209 | 342.742 | 378.196 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31.4 | 24.5 | 16.2 | 19.6 | 58.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 1,136.6 | 944.7 | 840.1 | 770.456 | 658.498 | 557.616 | 496.079 | 432.829 | 377.08 | 305.409 | 362.342 | 436.796 | 400.721 | 187.8 | 129.297 | 101.91 | 84.727 | 57.86 | 43.99 | 42.139 | 39.082 | 49.39 | 47.337 | 27.806 | 26.1 | 18.1 | 11.4 | 7.9 | 7.1 | 40.3 | 26.7 | 13.8 | 8.8 | 6.4 |
Other Expenses
| 475.5 | -164.8 | 4.9 | 296.42 | 192.177 | -0.79 | -81.382 | 4.13 | -6.713 | 30.4 | -72.669 | 44.987 | 124.754 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.3 | 4.5 | 3.6 | 3.2 | 3.7 | 3.5 | 3.9 | 2.8 | 1.8 | 0 |
Operating Expenses
| 4,775 | 3,485 | 3,891.2 | 2,599.993 | 2,413.038 | 1,974.092 | 1,820.704 | 1,480.519 | 1,373.25 | 1,160.915 | 1,281.125 | 1,242.981 | 1,108.427 | 825.216 | 679.982 | 618.202 | 597.781 | 429.573 | 292.53 | 234.301 | 238.718 | 252.408 | 196.01 | 112.727 | 104.6 | 81.3 | 66.6 | 46.3 | 52.3 | 43.8 | 30.6 | 16.6 | 10.6 | 6.4 |
Operating Income
| 4,307.5 | 4,307.4 | 2,782.1 | 2,856.29 | 1,197.566 | 635.15 | 123.243 | 9.936 | -468.662 | -692.412 | -903.448 | 2.332 | 113.82 | -696.077 | -613.412 | -462.708 | -419.792 | -229.038 | -149.872 | -154.807 | -264.527 | -119.604 | -91.803 | -38.682 | -39.6 | -32.4 | -19.2 | -29.8 | -26.5 | -20.7 | 1.2 | -10 | -5.6 | -4.1 |
Operating Income Ratio
| 0.436 | 0.482 | 0.367 | 0.46 | 0.288 | 0.208 | 0.05 | 0.006 | -0.454 | -1.193 | -0.745 | 0.002 | 0.081 | -4.855 | -6.011 | -2.636 | -2.109 | -1.059 | -0.932 | -1.507 | -3.826 | -0.742 | -0.548 | -0.495 | -0.643 | -0.73 | -0.438 | -2.241 | -1.199 | -1.056 | 0.043 | -2.632 | -1.75 | -1.783 |
Total Other Income Expenses Net
| 72.3 | -75 | -51.7 | 62.798 | 197.419 | -34.909 | -138.932 | -77.302 | -90.921 | -42.463 | -366.109 | -59.108 | -53.375 | -58.549 | -28.166 | 2.857 | 28.513 | 21.101 | -53.545 | -11.44 | 67.76 | 28.299 | -2.789 | -16.164 | 10.3 | 0 | 0 | 0 | 5.5 | 3.6 | 0.9 | 2 | 0.8 | 4.1 |
Income Before Tax
| 4,379.8 | 4,232.4 | 2,730.4 | 3,116.798 | 1,394.919 | 600.241 | -15.689 | -67.366 | -559.581 | -734.875 | -976.117 | -12.381 | 60.445 | -754.626 | -642.178 | -464.175 | -426.911 | -206.891 | -173.39 | -158.505 | -347.349 | -119.659 | -117.89 | -53.607 | -40.3 | 0 | 0 | -39.5 | -21 | -17.1 | 2.1 | -8 | -4.8 | 0 |
Income Before Tax Ratio
| 0.444 | 0.474 | 0.36 | 0.502 | 0.335 | 0.197 | -0.006 | -0.04 | -0.542 | -1.266 | -0.805 | -0.008 | 0.043 | -5.263 | -6.293 | -2.645 | -2.145 | -0.956 | -1.078 | -1.543 | -5.024 | -0.743 | -0.704 | -0.686 | -0.654 | 0 | 0 | -2.97 | -0.95 | -0.872 | 0.075 | -2.105 | -1.5 | 0 |
Income Tax Expense
| 760.2 | 910.4 | 388.3 | 405.151 | 218.109 | -1,486.862 | -107.324 | 16.665 | 30.381 | 6.958 | -288.567 | 38.754 | 19.266 | 19.275 | 19.336 | -30.729 | -21.394 | -18.496 | 61.679 | 29.014 | 24.064 | -10.983 | -1.916 | 0.976 | 1.4 | 0.7 | 0.6 | 10.2 | -5 | -3.1 | 0.1 | -1.5 | -0.5 | 4.3 |
Net Income
| 3,619.6 | 3,322 | 2,342.1 | 2,711.7 | 1,176.81 | 2,096.896 | 263.484 | -112.052 | -558.115 | -738.555 | -445.028 | -107.032 | 29.574 | -754.626 | -641.578 | -459.851 | -391.279 | -206.891 | -203.417 | -166.247 | -196.767 | -108.621 | -66.233 | -39.658 | -41 | -33.1 | -19.8 | -40 | -21.5 | -17.6 | 2 | -8.5 | -5.1 | -4.3 |
Net Income Ratio
| 0.367 | 0.372 | 0.309 | 0.437 | 0.283 | 0.688 | 0.106 | -0.066 | -0.541 | -1.272 | -0.367 | -0.07 | 0.021 | -5.263 | -6.287 | -2.62 | -1.966 | -0.956 | -1.264 | -1.618 | -2.846 | -0.674 | -0.395 | -0.508 | -0.666 | -0.745 | -0.452 | -3.008 | -0.973 | -0.898 | 0.072 | -2.237 | -1.594 | -1.87 |
EPS
| 14.05 | 12.97 | 9.09 | 10.44 | 4.58 | 8.25 | 1.06 | -0.46 | -2.32 | -3.14 | -1.98 | -0.5 | 0.14 | -3.77 | -3.7 | -3.27 | -3.03 | -1.83 | -2.28 | -2.12 | -2.56 | -1.43 | -0.89 | -0.59 | -0.8 | -0.65 | -0.41 | -1.07 | -0.63 | -0.56 | 0.08 | -0.35 | -0.35 | -0.33 |
EPS Diluted
| 13.89 | 12.82 | 9.01 | 10.29 | 4.51 | 8.09 | 1.04 | -0.46 | -2.31 | -3.14 | -1.98 | -0.5 | 0.14 | -3.77 | -3.7 | -3.27 | -3.03 | -1.83 | -2.28 | -2.12 | -2.56 | -1.43 | -0.89 | -0.59 | -0.8 | -0.65 | -0.41 | -1.07 | -0.63 | -0.56 | 0.08 | -0.35 | -0.35 | -0.33 |
EBITDA
| 4,605.2 | 4,435.5 | 2,917.5 | 3,284.464 | 1,560.362 | 706.78 | 103.258 | 75.464 | -411.251 | -598.755 | -554.753 | 42.463 | 133.938 | -704.892 | -598.879 | -426.188 | -385.214 | -199.519 | -114.449 | -107.593 | -264.527 | -123.053 | -97.137 | -24.651 | -44.3 | -43.2 | -15.6 | -36.3 | -22.8 | -17.2 | 5.1 | -7.2 | -3.8 | -4.1 |
EBITDA Ratio
| 0.467 | 0.487 | 0.368 | 0.514 | 0.35 | 0.218 | 0.125 | 0.009 | -0.458 | -1.053 | 0.416 | 0.003 | 0.157 | -4.619 | -5.318 | -2.603 | -1.9 | -0.933 | -0.565 | -1.011 | -0.961 | -0.584 | -0.144 | -0.188 | -0.529 | -0.628 | -0.356 | -1.271 | -1.281 | -1.061 | 0.133 | -2.421 | -1.438 | -1.783 |